1/30/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 1.09 | 138987.2 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |
1/27/2022 | 3002150000 | MEDICINES (MODIFIED IMMUNOLOGICAL PRODUCTS) INTENDED FOR CLINICAL STUDIES ACCORDING TO PROTOCOL BO40729, NOT ETHYL ALCOHOL, NOT FOR THERAPEUTIC USE, NOT FOR VETERINARY, NOT FOR SALE, (PACK B | 9.3 | 22973 | Ireland | SHEREMETIEVO 2 MOSCOW RUSSIA | REPRESENTATIVE OFFICE OF THE LLC F HOFFMANN LA ROCH LIMITED |
1/27/2022 | 3002150000 | DRUG FOR CLINICAL STUDY ACCORDING TO PROTOCOL No. BCD-201-1 - KEYTRUDA , CONCENTRATE FOR PREPARING SOLUTION FOR INFUSION 100 MG/4 ML BOTTLE, CARDBOARD PACK. | 1.2 | 119260.9 | Ireland | RIGA | CJSC BIOCAD |